Conference on personalised cancer therapy

Barcelona: 3-4 December 2012

The organisers of the IDIBELL Cancer Conference (ICC) on Personalized Cancer Medicine – Manel Esteller, George Thomas, Cristina Muñoz- Pinedo and Sara Kozma – will present 21speakers for the event, all leading oncologists and cancer researchers, particularly those working in the study of genetic and epigenetic defects leading to the selection of cancer patients for new drug therapies. The meeting aims to highlight the latest understanding of biological mechanisms and natural history of cancer, thus providing novel targets for therapy, as well as to discuss the molecular mechanisms involved in the stratification of oncology patents according to the recently described molecular markers. Special focus: Epigenetics and DNA Repair and the metabolism and cell signalling areas with the updated clinical applications. Details: http://bocemtium.com

05.11.2012

News • Study shows benefits of earlier FIT

Colorectal cancer screening: 40 is the new 50

Starting fecal immunochemical testing (FIT) early significantly reduces both the incidence and mortality of colorectal cancer. These results of a new study support earlier screening.

News • Assessment of tumour-infiltrating lymphocytes

Skin cancer: AI assistance helps pathologists identify melanoma

More consistent TIL assessments, more accurate patients' prognoses: New research shows how AI sharpens pathologists' interpretation of tissue samples for malignant melanoma.

News • Tumor microenvironment in nasopharyngeal carcinoma

Towards more personalized treatment of nose cancer

Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting personalised treatment.